Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - YUMANITY THERAPEUTICS, INC. | d51046dex312.htm |
| EX-31.1 - EX-31.1 - YUMANITY THERAPEUTICS, INC. | d51046dex311.htm |
| EX-23.1 - EX-23.1 - YUMANITY THERAPEUTICS, INC. | d51046dex231.htm |
| EX-21.1 - EX-21.1 - YUMANITY THERAPEUTICS, INC. | d51046dex211.htm |
| EX-10.14 - EX-10.14 - YUMANITY THERAPEUTICS, INC. | d51046dex1014.htm |
| EX-4.2 - EX-4.2 - YUMANITY THERAPEUTICS, INC. | d51046dex42.htm |
| 10-K - 10-K - YUMANITY THERAPEUTICS, INC. | d51046d10k.htm |
Exhibit 32.1
Certification Pursuant to
18 U.S.C. Section 1350
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report on Form 10-K of Yumanity Therapeutics, Inc. (the “Company”) for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of his knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: March 31, 2021 | /s/ Richard Peters | |||
| Richard Peters | ||||
| President and Chief Executive Officer (Principal Executive Officer) | ||||
| Date: March 31, 2021 | /s/ Paulash Mohsen | |||
| Paulash Mohsen | ||||
| Chief Business Officer (Principal Financial Officer) | ||||